Latest News Archive
Please select Category, Year, and then Month to display items
24 September 2024
|
Story Aimée Barlow
|
Photo Supplied
Louzanne Coetzee, who made history by clinching South Africa’s second medal at the Paralympics, earning a bronze in the T11 1 500 m women’s final with a personal best time, received a warm reception when she recently returned home.
The celebrated Paralympic bronze medallist Louzanne Coetzee returned home to a warm welcome at the Bram Fischer International Airport on 10 September 2024.
Family, friends, colleagues, Arista students, and media gathered to celebrate her remarkable achievement and show their support.
Coetzee – KovsieSport Coordinator of Parasport at the University of the Free State (UFS) – made history by clinching South Africa’s second medal at the Paralympics, earning a bronze in the T11 1 500 m women’s final with a personal best time. Her dedication and hard work have not only brought her personal glory but have also inspired many in her community.
Among those present to welcome her was Jerry Laka, Director of KovsieSport, who expressed his pride in Coetzee’s accomplishments.
"We as KovsieSport are so proud of our colleague Coetzee. It is amazing to see a product of KovsieSport achieving greatness on the world stage. She is truly an inspiration to us all," said Laka.
“I am so glad to be back, and to have Laka and my colleagues here. It means the world to me. Having Laka here shows his commitment to my career and ParaSport and his staff in general,” shared Coetzee, her gratitude evident.
She further expressed her appreciation for the support she received, stating, “I don’t have the words to describe how thankful I am for the support from the UFS community.”
Coetzee’s return is a proud moment for South Africa and the University of the Free State (UFS) community. Welcome home, Louzanne! Your achievements have made us all proud!
New Division of Virology to deliver crucial services for HIV diagnosis and resistance testing
2015-12-14
The establishment of a Division of Virology within the Department of Medical Microbiology, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology. Dr Dominique Goedhals, Head of the Division, says the division will also provide training of undergraduate medical students, medical technologists and technicians, and registrars. |
The newly established Division of Virology at the University of the Free State will be one of only five laboratories in the country to be involved in crucial diagnostic and testing services for HIV viral load monitoring, early infant diagnosis, and HIV resistance testing.
The Virology Diagnostic Laboratory serves as the reference laboratory for all HIV National Priority Programme samples for the Free State and Northern Cape provinces.
Medical staff at the laboratory will provide a 24-hour consultative service, as well as outreach programmes to district laboratories in the Free State and Northern Cape where pathologists are not available.
Dr Dominique Goedhals, Head of the Division of Virology, says this division, under the joint auspices of the UFS and the National Health Laboratory Service (NHLS), reflects the continued growth within Virology.
The division will not only deliver this critical diagnostic service, but will also focus on training and teaching, as well as research.
Teaching and training activities include teaching of undergraduate medical students, medical technologists and technicians, and registrars. The postgraduate science programme has a high output of honours, master’s and doctoral students in Virology. The intern medical scientist programme is also active, with five interns having successfully submitted their portfolios since the programme was implemented in 2010.
Research activities under the Head of Research, Prof Felicity Burt, have also expanded and continue to show increases in publication output and acquisition of grant funding. Established research groups within the Division of Virology focus on vector-borne and zoonotic viruses, human papilloma viruses (HPV), and human immunodeficiency virus (HIV), as well as work with a number of international collaborators.